D3i4AD Final Conference

You are invited to attend the D3i4AD Final Conference to hear about Diagnostic and Drug Discovery Initiatives for Alzheimer's Diseases as presented by our MSCA research fellows.  
As a delegate, you will also have the opportunity to do a 3 minute flash oral presentation (with 1 slide only) to accompany your poster presentation!  Please let us know if you would like to present your poster when you register!!

Photo Gallery

Friday 29 June 2018
8.00am - 6:00 pm

Brain Fallacara Department, 
via Dante Alighieri 99, 
70019 Triggiano (Ba) 

Click here for Google Maps

Via Giovanni Amendola, 184, 
70126 Bari BA, 
(60-70 euros / night)

Click here for Google Maps

Registration is free:

If you have any questions or concerns regarding the D3i4AD Final Conference, 
please contact:

Michela Bonomo
D3i4AD Research Fellow


Dr Jennifer Dick       
D3i4AD Project Manager                                    

Email: Jennifer.Dick@sheffield.ac.uk             

08.30-09.15 Coffee and Registration

09.15-09:30 Welcome and Introduction: Professor Beining Chen (University of Sheffield)

09:30-10.00 Keynote Speaker: Dr. David Evans (Eli Lilly) "Neurodegeneration Research in Industry"

10.00-10:30 Matthew Baumgartner (Eli Lilly) "Identification and refinement of Amyloid beta inhibitors by computational and experimental screening"

10:30-11:00     Cleide Dos Santos Souza ((University of Sheffield) "The role of Cellular Prion Protein (PrPC) in Alzheimer’s disease (AD): Drug development strategies for Alzheimer’s disease using human induced pluripotent stem cells (iPSCs)"

11:00-11:30 Coffee Break

11:30-12:00 James Grayson (University of Sheffield / Eli Lilly) "Screening a Compound Library Against Aβ Oligomers by 19F NMR”
12:00-12:30 Antonio de la Vega de Leon (University of Sheffield) "Modelling phenotypic assays using machine learning"

12:30-13:00 Flash Presentation for Posters for delegates  (3 min each – up to 10 delegates)

13:00-14:00 Lunch and Poster Presentation

14:00-14:30    Christina Founti (University of Sheffield / Eli Lilly) "Machine learning methods for the analysis and modelling of pharmaceutical data"

14:30-15:00 Maite Blázquez Sánchez (University of Lisbon) "Synthesis of C-glycosyl phenols as a strategy for the treatment of neurodegenerative diseases"  

15.00-15:30 João Manuel de Barros (University of Lisbon / Eli Lilly) "N-acetylgalactosamine mimetics: as potential Protein-Protein Interaction Inhibitors in Alzheimer’s Disease"

15:30-16:00 Coffee Break

16:00-16:30 Ana Marta de Matos (University of Lisbon / Eli Lilly) "Synthesis and optimization of C-glucosyl flavone analogues and aglycones with therapeutic potential against Alzheimer's disease"

16:30-17:00 Michela Bonomo (Biofordrug) "Effect of copper on prion protein biology: New possible target for treating and preventing Alzheimer’s disease."

17:00-18:00 Wine Reception and Prize Giving